Brainlab AG, a global leader in cancer-fighting medical technology, showed solidarity with the World Cancer Day campaign 'We Can. I Can.' by releasing a video in which employees share how they personally impact cancer. The three-year World Cancer Day campaign, outlines actions that people can take to prevent cancer, improve survival rates and reduce the impact cancer has on individuals, families and communities.
"Our research and development teams are constantly exploring ways to create less invasive cancer treatments, and making those treatments available to as many people as possible, even in the remote corners of the globe," said Stefan Vilsmeier, CEO and President of Brainlab. "Within our company, we are committed to disease prevention by providing a healthy work environment and educating and encouraging our employees to make healthy lifestyle choices both at work and home."
According to the Union for International Cancer Control (UICC), the global cancer epidemic is significant and is set to rise. Currently, there are 8.2 million cancer deaths per year worldwide, almost half of which are patients aged 30 to 69. The global occurrence is expected to rise to 13.2 million per year by 2030 with global cost of care estimated at $458 billion.(1,2,3,)
Through cross-disciplinary technologies bridging neuroscience and oncology, and not-for-profit initiatives spanning underserved regions around the globe, Brainlab products and services help clinicians personalize medical treatments, reduce risk to healthy tissue and advance cancer survival rates and improve quality of life. Technologies like Adaptive Hybrid Surgery and Multiple Brain Metastases SRS are available to assist in the treatment of cancer patients while corporate support of the Right.Brain Foundation e.V., brings neuronavigation technology and training to remote areas around the globe.
Corporate collaboration with leading cancer institutions around the globe, including Jefferson Hospital for Neuroscience, Rush University Medical Center and UCLA Medical Center in the U.S. and Charité - Universitätsmedizin Berlin and Klinikum der Ludwig-Maximilians-Universität Munich in Germany continue to foster innovation while advancing awareness and prevention of cancerous conditions of the brain and body.
"Brainlab is passionate about and proud of the contributions we make each and every day in the fight against cancer," concluded Vilsmeier. "The company and all of our employees will continue to increase our participation in cancer research and impact on treatment. World Cancer Day is a wonderful opportunity for us to demonstrate our commitment. Together We Can. Treat. Fight. Win."
About Brainlab
Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.
Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.
Privately held since its formation in 1989, Brainlab has over 9,000 systems installed in about 100 countries. Brainlab employs 1,300 people in 19 offices worldwide, including 320 research & development engineers, who form a crucial part of the product development team.
About World Cancer Day
A truly global event taking place every year on February 4, World Cancer Day unites the world's population in the fight against cancer.
It aims to prevent millions of preventable deaths each year by raising awareness and education about the disease, pressing governments and individuals across the world to take action.
1. About. (n.d.). Retrieved January 28, 2016, from http://www.worldcancerday.org/about
2. About UICC. (n.d.). Retrieved January 28, 2016, from http://www.uicc.org/priorities
3. Cancer Explained. (n.d.). Retrieved January 26, 2016, from http://www.worldcancerday.org/sites/wcd/files/private/130128_Cancer_Backgrounder.pdf